Literature DB >> 22715293

The glycated albumin to glycated haemoglobin ratio increases along with the fibrosis stage in non-alcoholic steatohepatitis.

Yukihiro Bando1, Hideo Kanehara, Keiko Aoki, Daishy Toya, Kazuo Notsumata, Nobuyoshi Tanaka, Hirayuki Enomoto, Shu-hei Nishiguchi, Keiji Nakasho, Hideji Nakamura, Soji Kasayama, Masafumi Koga.   

Abstract

BACKGROUND: We previously reported that the indicator of glycaemic control, glycated albumin (GA) levels, are low in relation to glycaemia in patients with high alanine aminotransferase (ALT) levels in non-alcoholic fatty liver disease because of chronic inflammation, and that the GA/glycated haemoglobin ratio (G/H ratio) is inversely correlated with hepatic function in patients with chronic liver disease. The severity of liver fibrosis is known to be a good indicator for surveillance, and for determining the prognosis and optimal treatment of non-alcoholic steatohepatitis (NASH). In this study, we aimed to investigate the clinical usefulness of measuring the G/H ratio for predicting the severity of liver fibrosis in patients with NASH.
METHODS: The study subjects were 36 patients with histologically diagnosed NASH (19 men, 17 women; mean age 54.8±12.2 years, body mass index 28.3±5.0 kg/m2). The relationships of the G/H ratio to hepatic function tests and fibrosis stage in the liver were investigated.
RESULTS: The G/H ratio in patients with NASH was inversely correlated with ALT (P<0.001) and platelet count (P<0.0001). Furthermore, the G/H ratio was positively correlated with the fibrosis stage in liver (P=0.003).
CONCLUSIONS: These results suggest that the G/H ratio increases along with the fibrosis stage in patients with NASH.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22715293     DOI: 10.1258/acb.2012.011139

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  4 in total

Review 1.  Liver fibrosis markers of nonalcoholic steatohepatitis.

Authors:  Hirayuki Enomoto; Yukihiro Bando; Hideji Nakamura; Shuhei Nishiguchi; Masafumi Koga
Journal:  World J Gastroenterol       Date:  2015-06-28       Impact factor: 5.742

2.  A new metabolism-related index correlates with the degree of liver fibrosis in hepatitis C virus-positive patients.

Authors:  Hirayuki Enomoto; Nobuhiro Aizawa; Hideji Nakamura; Ryo Takata; Yoshiyuki Sakai; Yoshinori Iwata; Hironori Tanaka; Naoto Ikeda; Tomoko Aoki; Kunihiro Hasegawa; Kazunori Yoh; Kenji Hashimoto; Akio Ishii; Tomoyuki Takashima; Masaki Saito; Hiroyasu Imanishi; Hiroko Iijima; Shuhei Nishiguchi
Journal:  Gastroenterol Res Pract       Date:  2015-03-11       Impact factor: 2.260

3.  Serum zinc value in patients with hepatitis virus-related chronic liver disease: association with the histological degree of liver fibrosis and with the severity of varices in compensated cirrhosis.

Authors:  Kazunari Iwata; Hirayuki Enomoto; Shuhei Nishiguchi; Nobuhiro Aizawa; Yoshiyuki Sakai; Yoshinori Iwata; Hironori Tanaka; Naoto Ikeda; Tomoyuki Takashima; Masaki Saito; Hiroyasu Imanishi; Hiroko Iijima; Yasuhiro Tsuda; Kazuhide Higuchi
Journal:  J Clin Biochem Nutr       Date:  2014-07-26       Impact factor: 3.114

4.  An Increased Ratio of Glycated Albumin to HbA1c Is Associated with the Degree of Liver Fibrosis in Hepatitis B Virus-Positive Patients.

Authors:  Hirayuki Enomoto; Nobuhiro Aizawa; Hideji Nakamura; Yoshiyuki Sakai; Yoshinori Iwata; Hironori Tanaka; Naoto Ikeda; Tomoko Aoki; Yukihisa Yuri; Kazunori Yoh; Kenji Hashimoto; Akio Ishii; Tomoyuki Takashima; Kazunari Iwata; Masaki Saito; Hiroyasu Imanishi; Hiroko Iijima; Shuhei Nishiguchi
Journal:  Gastroenterol Res Pract       Date:  2014-02-17       Impact factor: 2.260

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.